메뉴 건너뛰기




Volumn 174, Issue 1-3, 2016, Pages 93-98

Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia

Author keywords

Akathisia; Brexpiprazole; D2 partial agonist; Safety; Schizophrenia; Sedation

Indexed keywords

ARIPIPRAZOLE; BREXPIPRAZOLE; CHOLESTEROL; CREATINE KINASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LORAZEPAM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROLACTIN; TRIACYLGLYCEROL; NEUROLEPTIC AGENT; QUINOLONE DERIVATIVE; THIOPHENE DERIVATIVE;

EID: 84967261783     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2016.04.013     Document Type: Article
Times cited : (53)

References (31)
  • 1
    • 0024358369 scopus 로고
    • A rating scale for drug-induced akathisia
    • Barnes T.R. A rating scale for drug-induced akathisia. Br. J. Psychiatry 1989, 154(5):672-676.
    • (1989) Br. J. Psychiatry , vol.154 , Issue.5 , pp. 672-676
    • Barnes, T.R.1
  • 2
    • 80055087317 scopus 로고    scopus 로고
    • Aripiprazole versus placebo for schizophrenia
    • Belgamwar R.B., El-Sayeh H.G. Aripiprazole versus placebo for schizophrenia. Cochrane Database Syst. Rev. 2011, 8:CD006622. 10.1002/14651858.CD14006622.pub14651852.
    • (2011) Cochrane Database Syst. Rev. , vol.8 , pp. CD006622
    • Belgamwar, R.B.1    El-Sayeh, H.G.2
  • 3
    • 34247542475 scopus 로고    scopus 로고
    • Quetiapine and long-term weight change: a comprehensive data review of patients with schizophrenia
    • Brecher M., Leong R.W., Stening G., Osterling-Koskinen L., Jones A.M. Quetiapine and long-term weight change: a comprehensive data review of patients with schizophrenia. J. Clin. Psychiatry 2007, 68(4):597-603.
    • (2007) J. Clin. Psychiatry , vol.68 , Issue.4 , pp. 597-603
    • Brecher, M.1    Leong, R.W.2    Stening, G.3    Osterling-Koskinen, L.4    Jones, A.M.5
  • 5
    • 33750614310 scopus 로고    scopus 로고
    • Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine
    • Chrzanowski W.K., Marcus R.N., Torbeyns A., Nyilas M., McQuade R.D. Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine. Psychopharmacology 2006, 189(2):259-266.
    • (2006) Psychopharmacology , vol.189 , Issue.2 , pp. 259-266
    • Chrzanowski, W.K.1    Marcus, R.N.2    Torbeyns, A.3    Nyilas, M.4    McQuade, R.D.5
  • 6
    • 84887097223 scopus 로고    scopus 로고
    • A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach
    • Citrome L. A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach. CNS Drugs 2013, 27(11):879-911.
    • (2013) CNS Drugs , vol.27 , Issue.11 , pp. 879-911
    • Citrome, L.1
  • 7
    • 77954166205 scopus 로고    scopus 로고
    • From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics
    • Correll C.U. From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics. Eur. Psychiatry 2010, 25(Suppl. 2):S12-S21.
    • (2010) Eur. Psychiatry , vol.25 , pp. S12-S21
    • Correll, C.U.1
  • 9
    • 84964734763 scopus 로고    scopus 로고
    • Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, doubleblind, placebo-controlled studies
    • Correll C.U., et al. Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, doubleblind, placebo-controlled studies. Schizophr. Res. 2016, 10.1016/j.schres.2016.04.012.
    • (2016) Schizophr. Res.
    • Correll, C.U.1
  • 10
    • 84856466929 scopus 로고    scopus 로고
    • Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
    • De Hert M., Detraux J., van Winkel R., Yu W., Correll C.U. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat. Rev. Endocrinol. 2011, 8(2):114-126.
    • (2011) Nat. Rev. Endocrinol. , vol.8 , Issue.2 , pp. 114-126
    • De Hert, M.1    Detraux, J.2    van Winkel, R.3    Yu, W.4    Correll, C.U.5
  • 11
    • 84865253275 scopus 로고    scopus 로고
    • Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis
    • De Hert M., Yu W., Detraux J., Sweers K., van Winkel R., Correll C.U. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis. CNS Drugs 2012, 26(9):733-759.
    • (2012) CNS Drugs , vol.26 , Issue.9 , pp. 733-759
    • De Hert, M.1    Yu, W.2    Detraux, J.3    Sweers, K.4    van Winkel, R.5    Correll, C.U.6
  • 12
    • 0006618558 scopus 로고
    • ECDEU assessment manual for psychopharmacology (revised)
    • National Institute of Mental Health, US Department of Health, Education, and Welfare Publication (ADM) 76-338, Rockville, MD, M. Hamilton (Ed.)
    • Guy W. ECDEU assessment manual for psychopharmacology (revised). Hamilton Anxiety Scale 1976, 193-198. National Institute of Mental Health, US Department of Health, Education, and Welfare Publication (ADM) 76-338, Rockville, MD. M. Hamilton (Ed.).
    • (1976) Hamilton Anxiety Scale , pp. 193-198
    • Guy, W.1
  • 13
    • 84924968394 scopus 로고    scopus 로고
    • Validity of subjective versus objective quality of life assessment in people with schizophrenia
    • Hayhurst K.P., Massie J.A., Dunn G., Lewis S.W., Drake R.J. Validity of subjective versus objective quality of life assessment in people with schizophrenia. BMC Psychiatry 2014, 14(1):365.
    • (2014) BMC Psychiatry , vol.14 , Issue.1 , pp. 365
    • Hayhurst, K.P.1    Massie, J.A.2    Dunn, G.3    Lewis, S.W.4    Drake, R.J.5
  • 15
    • 77951165069 scopus 로고    scopus 로고
    • Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar i disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials
    • Kane J.M., Barnes T.R., Correll C.U., Sachs G., Buckley P., Eudicone J., McQuade R., Tran Q.V., Pikalov A., Assuncao-Talbott S. Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar i disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. J. Psychopharmacol. 2010, 24(7):1019-1029.
    • (2010) J. Psychopharmacol. , vol.24 , Issue.7 , pp. 1019-1029
    • Kane, J.M.1    Barnes, T.R.2    Correll, C.U.3    Sachs, G.4    Buckley, P.5    Eudicone, J.6    McQuade, R.7    Tran, Q.V.8    Pikalov, A.9    Assuncao-Talbott, S.10
  • 16
    • 84928640856 scopus 로고    scopus 로고
    • A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
    • Kane J.M., Skuban A., Ouyang J., Hobart M., Pfister S., McQuade R.D., Nyilas M., Carson W.H., Sanchez R., Eriksson H. A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia. Schizophr. Res. 2015, 164(1-3):127-135.
    • (2015) Schizophr. Res. , vol.164 , Issue.1-3 , pp. 127-135
    • Kane, J.M.1    Skuban, A.2    Ouyang, J.3    Hobart, M.4    Pfister, S.5    McQuade, R.D.6    Nyilas, M.7    Carson, W.H.8    Sanchez, R.9    Eriksson, H.10
  • 17
    • 84936931469 scopus 로고    scopus 로고
    • Efficacy and safety of cariprazine in acute exacerbation of schizophrenia: results from an international, phase III clinical trial
    • Kane J.M., Zukin S., Wang Y., Lu K., Ruth A., Nagy K., Laszlovszky I., Durgam S. Efficacy and safety of cariprazine in acute exacerbation of schizophrenia: results from an international, phase III clinical trial. J. Clin. Psychopharmacol. 2015, 35(4):367-373.
    • (2015) J. Clin. Psychopharmacol. , vol.35 , Issue.4 , pp. 367-373
    • Kane, J.M.1    Zukin, S.2    Wang, Y.3    Lu, K.4    Ruth, A.5    Nagy, K.6    Laszlovszky, I.7    Durgam, S.8
  • 18
    • 0034025771 scopus 로고    scopus 로고
    • Relationship between dopamine d(2) occupancy, clinical response, and side effects: a double-blind pet study of first-episode schizophrenia
    • Kapur S., Zipursky R., Jones C., Remington G., Houle S. Relationship between dopamine d(2) occupancy, clinical response, and side effects: a double-blind pet study of first-episode schizophrenia. Am. J. Psychiatry 2000, 157(4):514-520.
    • (2000) Am. J. Psychiatry , vol.157 , Issue.4 , pp. 514-520
    • Kapur, S.1    Zipursky, R.2    Jones, C.3    Remington, G.4    Houle, S.5
  • 20
    • 84898057496 scopus 로고    scopus 로고
    • 2a receptor antagonists for the treatment of neuroleptic-induced akathisia: a systematic review and meta-analysis
    • 2a receptor antagonists for the treatment of neuroleptic-induced akathisia: a systematic review and meta-analysis. Int. J. Neuropsychopharmacol. 2014, 17(5):823-832.
    • (2014) Int. J. Neuropsychopharmacol. , vol.17 , Issue.5 , pp. 823-832
    • Laoutidis, Z.G.1    Luckhaus, C.2
  • 24
    • 16644402581 scopus 로고    scopus 로고
    • A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study
    • McQuade R.D., Stock E., Marcus R., Jody D., Gharbia N.A., Vanveggel S., Archibald D., Carson W.H. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study. J. Clin. Psychiatry 2004, 65(Suppl. 18):47-56.
    • (2004) J. Clin. Psychiatry , vol.65 , pp. 47-56
    • McQuade, R.D.1    Stock, E.2    Marcus, R.3    Jody, D.4    Gharbia, N.A.5    Vanveggel, S.6    Archibald, D.7    Carson, W.H.8
  • 25
    • 25444533069 scopus 로고    scopus 로고
    • Atypical antipsychotics: sleep, sedation, and efficacy
    • Miller D.D. Atypical antipsychotics: sleep, sedation, and efficacy. Prim. Care Companion. J. Clin. Psychiatry. 2004, 6(Suppl. 2):3-7.
    • (2004) Prim. Care Companion. J. Clin. Psychiatry. , vol.6 , pp. 3-7
    • Miller, D.D.1
  • 27
    • 84555186903 scopus 로고    scopus 로고
    • Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons
    • Rummel-Kluge C., Komossa K., Schwarz S., Hunger H., Schmid F., Kissling W., Davis J.M., Leucht S. Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons. Schizophr. Bull. 2012, 38(1):167-177.
    • (2012) Schizophr. Bull. , vol.38 , Issue.1 , pp. 167-177
    • Rummel-Kluge, C.1    Komossa, K.2    Schwarz, S.3    Hunger, H.4    Schmid, F.5    Kissling, W.6    Davis, J.M.7    Leucht, S.8
  • 28
    • 22144432283 scopus 로고    scopus 로고
    • A systematic review of the prevalence of schizophrenia
    • Saha S., Chant D., Welham J., McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005, 2(5):e141.
    • (2005) PLoS Med. , vol.2 , Issue.5 , pp. e141
    • Saha, S.1    Chant, D.2    Welham, J.3    McGrath, J.4
  • 29
    • 17844406880 scopus 로고    scopus 로고
    • Olanzapine increases slow wave sleep and sleep continuity in ssri-resistant depressed patients
    • Sharpley A.L., Attenburrow M.E., Hafizi S., Cowen P.J. Olanzapine increases slow wave sleep and sleep continuity in ssri-resistant depressed patients. J. Clin. Psychiatry 2005, 66(4):450-454.
    • (2005) J. Clin. Psychiatry , vol.66 , Issue.4 , pp. 450-454
    • Sharpley, A.L.1    Attenburrow, M.E.2    Hafizi, S.3    Cowen, P.J.4
  • 31
    • 68149160037 scopus 로고    scopus 로고
    • Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making
    • Volavka J., Citrome L. Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making. Expert. Opin. Pharmacother. 2009, 10(12):1917-1928.
    • (2009) Expert. Opin. Pharmacother. , vol.10 , Issue.12 , pp. 1917-1928
    • Volavka, J.1    Citrome, L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.